RxDoctor Payments DataLook up a doctor →

Philippe Backeljauw

Pediatric Endocrinology · Cincinnati, OHNPI 1770511883

Payments from drug & device makers

$3,039,519in general payments, 2019–2025

Across 929 payments — averaging $3271.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1.5M
  • Ipsen Biopharmaceuticals, Inc$859K
  • Biomarin Pharmaceutical Inc.$245K
  • Ascendis Pharma Endocrinology Inc$174K
  • Novo Nordisk Health Care AG$98K
  • Novo Nordisk AS$92K
  • plus $73K from 14 others

What the payments were for

  • Consulting fees$168,27627%
  • Speaking & faculty fees$318,30650%
  • Travel & lodging$135,15521%
  • Food & beverage$10,4052%
  • Education$2840%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,039,519 in reported general payments places this provider in the 95th percentile of 76 pediatric endocrinology providers in Ohio.

See all pediatric endocrinology providers in Ohio

Other pediatric endocrinology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →